Proteins and Peptides

16 Mar 2007 Affibody to publish data on therapeutic effects of Affibody(R) molecules in a cancer model
16 Mar 2007 Aida Pharmaceuticals Initiates Preclinical Research of Potential Anti-Cancer Treatment Vasostatin-Apo2L
16 Mar 2007 Neose Receives FDA Clearance to Commence U.S. Clinical Trials for NE-180
16 Mar 2007 Pacgen completes patient recruitment for Phase I/II trial of novel anti-fungal drug
15 Mar 2007 Lev Pharmaceuticals, Inc. Reports Positive Results in Pivotal Phase III Trial for Hereditary Angioedema
14 Mar 2007 Ambrilia and Mallinckrodt Announce IND Filing for Phase III Clinical Study of Improved Octreotide Formulation
14 Mar 2007 Maxygen Announces End of Co-Development Agreement
13 Mar 2007 Cangene Receives an Approvable Letter From the FDA for Human Growth Hormone
13 Mar 2007 Chemokine Therapeutics Announces Preliminary Results of CTCE-9908 Phase IB/II Clinical Trial in Late Stage Cancer Patients
10 Mar 2007 Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
09 Mar 2007 Data From Adherex's European Phase Ib/II Trial of ADH-1 to be Presented at International Symposium on Targeted Anticancer Therapies
09 Mar 2007 Alba Announces Completion of Enrollment and Dosing of Patients in Phase II Clinical Trial of AT-1001 for the Treatment of Celiac Disease
08 Mar 2007 ZymoGenetics Provides Update on rhThrombin Development Plans
08 Mar 2007 Allon product AL-108 successful in Phase Ib clinical trial
07 Mar 2007 Clinquest Group and TNO sign licensing agreement on protein for inflammatory disorders
07 Mar 2007 AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy
07 Mar 2007 Nautilus Biotech and HanAll Pharmaceutical announce license agreement to develop three Nautilus Biotech products in South Korea
06 Mar 2007 Cytheris Releases Promising Clinical Data on its Interleukin-7 Immune Enhancer at the 2007 CROI Meeting in Los Angeles
06 Mar 2007 Transition Therapeutics Announces Positive Data from E1-I.N.T.(TM) Clinical Trials in Type 1 and Type 2 Diabetes Patients
06 Mar 2007 InterMune Discontinues Phase 3 INSPIRE Trial of Actimmune in Idiopathic Pulmonary Fibrosis
03 Mar 2007 GTC Biotherapeutics Enters Into Process Development And Clinical Supply Manufacturing Services Agreement With Pharmathene For Protexia
02 Mar 2007 Biolex Therapeutics Researchers Present Preclinical Data for Direct-Acting Thrombolytic BLX-155 at Scientific Conference
02 Mar 2007 Levemir(R) approved in Europe for use in combination with oral antidiabetic drugs
02 Mar 2007 Results with New Integrase Inhibitor Plus FUZEON and Boosted Protease Inhibitor Show Remarkable Undetectable Rate of 98 Percent in Treatment-Experienced HIV Patients
02 Mar 2007 Kamada begins phase III clinical trial in the U.S. with its Alpha-1 Antitrypsin product indicated for Congenital Emphysema

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing